Skip to main content
. 2015 Aug 11;6:7934. doi: 10.1038/ncomms8934

Table 2. Rates of Axis I diagnoses during follow-up in young people at ultrahigh risk for psychosis at baseline.

Diagnosis Entire sample (N=69)
Omega-3 group (N=34)
Placebo group (N=35)
  N % N % N %
Any disorder 47 68.1 18 52.9 29 82.9
             
Psychotic disorder 20 29.0 4 11.8 16 45.7
 Schizophrenia, paranoid type 11 15.9 2 5.9 9 25.7
 Schizophreniform disorder 2 2.9 1 2.9 1 2.9
 Schizoaffective disorder 4 5.8 1 2.9 3 8.6
 Psychosis NOS 2 2.9 0 0.0 2 5.7
 Bipolar I disorder with psychotic features 1 1.4 0 0.0 1 2.9
             
Mood disorder 26 37.7 13 38.2 13 37.1
 Major depressive disorder 24 34.8 12 35.3 12 34.3
 Bipolar II disorder 2 2.9 1 2.9 1 2.9
             
Anxiety disorder 19 27.5 9 26.5 10 28.6
 Anxiety disorder with agoraphobia 2 2.9 1 2.9 1 2.9
 Anxiety disorder without agoraphobia 4 5.8 1 2.9 3 8.6
 Anxiety disorder NOS 4 5.8 2 5.9 2 5.7
 Social Phobia 5 7.2 3 8.8 2 5.7
 Obsessive compulsive disorder 4 5.8 2 5.9 2 5.7
             
Substance use disorders 7 10.1 2 5.9 5 14.3
 Alcohol abuse 2 2.9 1 2.9 1 2.9
 Alcohol dependence 1 1.4 1 2.9 0 0.0
 Cannabis abuse 4 5.8 0 0.0 4 11.4
             
Other disorders 3 4.3 0 0.0 3 8.6
 Bulimia nervosa 1 1.4 0 0.0 1 2.9
 Eating disorder NOS 1 1.4 0 0.0 1 2.9
 Somatization disorder 1 1.4 0 0.0 1 2.9